FDA expert panel endorses removing a flu vaccine component

Plus: Three questions for the future of Biden's cancer moonshot, and the latest on the cancer drug shortage

October 5, 2023 Check out STAT+

Sponsored By

Adobe Cancer drug shortage eases slightly, but it's still 'living from paycheck to paycheck' A survey shows 86% of cancer centers lack supplies of a generic chemotherapy drug, putting extra strain on children's cases. By Elizabeth Cooney STAT+ | Neurocrine reports second late-stage trial success for congenital adrenal hyperplasia drug It marks the second success the company has reported in the past month for a drug observers believe has blockbuster potential. By Jonathan Wosen Scientists want to put carbon footprints on drugs. But it's hard to get accurate numbers For pharma and biotech companies, about 90% of emissions come from indirect sources that can be difficult to estimate. By Betsy Ladyzhets Elise Amendola/AP STAT+ | 3 questions for the future of Biden's cancer moonshot The original funding for the cancer moonshot has run out. If Congress renews it, it'll have to think hard about the program's future. By John Wilkerson STAT+ | Failed biotech gives a rare peek inside the tough breaks — and tough choices — that led to its demise The regenerative medicine firm's unraveling provides a glimpse into conversations other biotechs are undoubtedly having behind closed doors. By Jonathan Wosen The future of health care in the House STAT reviews the health care histories of House Speaker candidates Reps. Steve Scalise (R-La.) and Jim Jordan (R-Ohio). By Rachel Cohrs Patrick Sison/AP FDA expert panel endorses idea of removing a component from flu vaccine The move follows a recommendation from the WHO to remove the influenza B/Yamagata component from the flu vaccines. By Helen Branswell

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser